Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Following from the gait protocol paper, this work shows that gait measures correlate with biochemical measures of disease processes. Specifically, CSF measures of Abeta peptide ratios correlated with step-time and step-length suggesting that early AD pathology affects the cognitive and motor control of gait.

Original publication

DOI

10.3233/JAD-180622

Type

Journal article

Publication Date

25/09/2018

Volume

65

Pages

1377 - 1383

Addresses

https://content.iospress.com/articles/journal-of-alzheimers-disease/jad180622

Keywords

Alzheimer’s disease, , amyloid, , biomarkers, , cerebrospinal fluid proteins, , gait